XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Award Activity

The following is a summary of the stock option award activity during the three months ended March 31, 2024:

 

 

 

Number
of Stock
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2023

 

 

6,695,933

 

 

$

3.52

 

 

 

8.32

 

 

$

361

 

Granted

 

 

1,690,675

 

 

 

1.24

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(50,335

)

 

 

4.43

 

 

 

 

 

 

 

Outstanding at March 31, 2024

 

 

8,336,273

 

 

$

3.05

 

 

 

8.49

 

 

$

40

 

Exercisable at March 31, 2024

 

 

2,797,539

 

 

$

5.04

 

 

 

7.45

 

 

$

17

 

Options expected to vest as of March 31, 2024

 

 

5,538,734

 

 

$

2.05

 

 

 

9.02

 

 

$

23

 

Schedule of Estimating Fair Value of the Stock Options and Common stock Warrants Granted The following table presents the assumptions and the Company’s methodology for developing each of the assumptions used:

 

 

 

March 31,
2024

 

March 31,
2023

Volatility

 

94.20% - 102.54%

 

91.91%

Expected life (years)

 

6.08

 

6.08

Risk-free interest rate

 

3.98% - 4.16%

 

3.99%

Dividend rate

 

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense was recorded in the following line items in the condensed statements of operations for the three months ended March 31, 2024 and 2023 (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

532

 

 

$

389

 

General and administrative

 

 

708

 

 

 

470

 

Total stock-based compensation expense

 

$

1,240

 

 

$

859